Table 1.
Summary of prostate MRI public datasets
| Number | Dataset | Data source | Modalities | Dataset size | Acquisition years | Files size | Data type | Field strength | Scanner manufacturer and model | Coil type | Clinical variables | Purpose | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PROSTATE-MRI | TNCI | MRI (triplanar T2W, DWI, pre-contrast T1W, DCE) | MRI cases (n = 26), pathology images (n = 26) | 2008–2010 | 3.4 GB | MRI cases (DICOM), pathology images (JPEG) | 3 T | Philips Achieva | Endorectal | Gleason grade (n = 26) | Disease classification | [20] |
| 2 | Prostate Fused-MRI-Pathology | WRUHC, HUP | MRI (triplanar T2W, DWI, pre-contrast T1W, DCE) | MRI cases (n = 28), pathology images (n = 16) | 2009–2011 | 81.2 GB | MRI cases (DICOM), pathology images (TIFF, XML) | 3 T | Siemens Verio | Endorectal | Not reported | Disease classification | [21] |
| 3 | Prostate-3T | RUMC | MRI (axial T2W) | MRI cases (n = 64), SV and NVB segmentations (n = 15) | 2003–2005 | 610 MB | MRI cases (DICOM), SV and NVB segmentations (MHA) | 3 T | Siemens Trio | Pelvic phased-array surface | Not reported | Cancer detection | [22] |
| 4 | ICCVB | Not reported | MRI (axialT2W, DWI, DCE, ADC) | MRI cases (n = 12) | Not reported | 5.6 GB | MRI cases (DICOM) | 1.5 T (n = 7), 3 T (n = 5) | GE (n = 7), Siemens (n = 5) | Endorectal (n = 7), phased-array surface (n = 5) | Not reported | Cancer detection | [23] |
| 5 | TCGA-PRAD | UPMC, WHSL, LHMC | MRI (axial T2W, DWI, pre-contrast T1W, DCE, ADC), CT, PET | MRI cases (n = 10), CT images (n = 4), PET images (n = 3), pathology images (n = 14), genomics data (n = 14) | Not reported | 3.74 GB | MRI cases (DICOM), CT images (DICOM), PET images (DICOM), pathology images (WEB), genomics data (WEB) | 1.5 T | GE Signa HDx | Endorectal | PSA (n = 14), Gleason grade (n = 14), lesion location (n = 14), TNM classification (n = 14) | Disease classification, Cancer detection | [24] |
| 6 | PROSTATE-DIAGNOSIS | BMC | MRI (axial and coronal T2W, DWI, pre-contrast T1W, DCE) | MRI cases (n = 92), SV and NVB segmentations (n = 15), zones and lesions segmentations (n = 5) | 2008–2010 | 5.6 GB | MRI cases (DICOM), SV and NVB segmentations (MHA), zones and lesions segmentations (NRRD) | 1.5 T | Philips Achieva | Endorectal | Full report for: MRI (n = 54), biopsy (n = 43), specimen (n = 25), treatment (n = 52) | Disease classification, Cancer detection | [25] |
| 7 | Prostate-MRI-US-Biopsy | UCCUC | MRI (axial T2W), Ultrasound | MRI cases (n = 842), ultrasound cases (n = 1,151), gland and lesions segmentations (n = 1,150) | 2004–2011 | 78.2 GB | MRI cases (DICOM), ultrasound cases (DICOM), gland and lesions segmentations (STL) | MRI: 3 T (n = 807), 1.5 T (n = 35). Ultrasoun: 2–10 MHz | MRI: Siemens Skyra (n = 609), Siemens Vida (n = 60), Siemens Prisma (n = 38), Siemens Verio (n = 36), Siemens Trio (n = 32), Siemens Avanto (n = 31), Siemens Espree (n = 1), GE Discovery MR750w (n = 14), GE Signa HDx (n = 10), GE Optima MR450w (n = 2), Philips Achieva (n = 5), Philips Ingenia (n = 4). Ultrasound: Hitachi Hi-Vision, Noblus C41V | MRI: Transabdominal phased-array surface. Ultrasound: End-fire probe | PIRADS (n = 840), PSA (n = 1146), Gleason grade (n = 196), prostate volume (n = 1,150), lesion location (n = 1,150) | Disease classification, Cancer detection | [26] |
| 8 | QIN PROSTATE | BWH | MRI (axial T2W, DWI, pre-contrast T1W, DCE, ADC) | MRI cases (n = 22) | Not reported | 4.4 GB | MRI cases (DICOM) | 3 T | GE Signa HDx | Endorectal | Not reported | Disease classification, Cancer detection | [27] |
| 9 | QIN-PROSTATE-Repeatability | BWH | MRI (axial T2W, DWI, DCE, ADC) | MRI cases (n = 15) zones and lesions segmentations (n = 15) | 2013–2015 | 14.86 GB | MRI cases (DICOM), zone and lesions segmentations (DICOM) | 3 T | GE Signa HDx | Endorectal | Not reported | Repeatability measurements, Disease classification | [28] |
| 10 | SPIE-AAPM-NCI PROSTATEx Challenges | RUMC | MRI (triplanar T2W, DWI, DCE, ADC, PDW) | MRI cases (n = 346), Ktrans images (n = 345), thumbnails images (n = 345) | 2012 | 15.4 GB | MRI cases (DICOM), Ktrans images (MHD), thumbnail images (BMP) | 3 T | Siemens Trio (n = 57), Siemens Skyra (n = 289) | Pelvic phased-array surface | Lesion location (n = 344), significant/insignificant cancer (n = 204), Gleason grade group (n = 99) | Disease classification, Cancer detection | [18, 29] |
| 11 | NCI-ISBI 2013 ASPS Challenge | BMC, RUMC | MRI (axial T2W) | MRI cases (n = 80), zones segmentations (n = 80) | 2003–2010 | 600 MB | MRI cases (DICOM), zones segmentations (NRRD) | 1.5 T (n = 40), 3 T (n = 40) | Philips Achieva (n = 40), Siemens Trio (n = 40) | Endorectal (n = 40), pelvic phased-array surface (n = 40) | Not reported | Zones segmentation | [30, 31] |
| 12 | PROMISE12 Challenge | HUH, BIDMC, UCL, RUMC | MRI (axial T2W) | MRI cases (n = 80), whole gland segmentations (n = 50) | Not reported | 1.2 GB | MRI cases (MHD), gland segmentations (MHD) | 1.5 T (n = 30), 3 T (n = 50) | GE (n = 20), Semiens (n = 60) | Endorectal (n = 41), phased-array surface (n = 39) | Not reported | Whole gland segmentation | [32, 33] |
| 13 | Medical Segmentation Decathlon | RUMC | MRI (axial T2W, ADC) | MRI cases (n = 48), zones segmentations (n =32) | Not reported | 229 MB | MRI cases (NII.GZ), zones segmentations (NII.GZ) | 3 T | Not reported | Phased-array surface coil | Not reported | Zones segmentation | [34, 35] |
| 14 | QUBIQ21 Challenge | Not reported | MRI (axial T2W) | MRI cases (n = 55), whole and central gland segmentations (n = 55 [327 masks]) | Not reported | 2.04 GB | MRI cases (NII.GZ), whole and central gland segmentations (NII.GZ) | Not reported | Not reported | Endorectal | Not reported | Segmentation uncertainty estimation | [17] |
| 15 | NCIGT-PROSTATE | BMWH | MRI (triplanar T2W) | MRI cases (n = 10), gland segmentations (n = 10) | Not reported | 768 MB | MRI cases (DICOM) | 3 T | GE Signa HDx | Endorectal | Not reported | Whole gland segmentation | [36] |
| 16 | PI-CAI Challenge | RUMC, UMCG, ZGT | MRI (triplanar T2W, DWI, ADC) | MRI cases (n = 1,500), lesions segmentations (n = 1,295) | 2012-2021 | 32.5 GB | MRI cases (MHA), lesions segmentations (NII.GZ) | 1.5 T (n = 82), 3 T (n = 1,418) | Siemens ([Skyra 3 T, TrioTim 3 T, Prisma 3 T, Aera 1.5 T, Avanto 1.5 T, Espree 1.5 T]; n = 1,221), Philips ([Ingenia 3 T, Achieva 1.5 T, Intera 1.5 T]; n = 279) | Phased-array surface coil | Age (n = 1,500), PSA (n = 1,460), PSA density (n = 1,047), Gleason grade (n = 1,001), prostate volume (n = 1,473), histopathology type (n = 1,001) | Disease classification, Cancer detection | [37, 38] |
| 17 | Prostate158 | CUB | MRI (axial T2W, DWI, ADC) | MRI cases (n = 139), zones segmentation (n = 139), lesions segmentations (n = 83) | Not reported | 2.6 GB | MRI cases (NII.GZ), zones and lesions segmentations (NII.GZ) | 3 T | Not reported | Phased-array surface coil | Not reported | Zones segmentation, Cancer detection | [39] |
ADC Apparent diffusion coefficient; BIDMC Beth Israel Deaconess Medical Center, Boston, MA, USA; BMC Boston Medical Center, Boston, MA, USA; BWH Brigham and Women’s Hospital, Boston, MA, USA; CT Computed Tomography; CUB Charité-Universitätsmedizin Berlin, Berlin, Germany; DCE Dynamic contrast-enhanced; DWI Diffusion-weighted imaging; GE General Electric Healthcare Systems, Milwaukee, WI, USA; HUH Haukeland University Hospital, Bergen, Norway; HUP Hospital of the University of Pennsylvania, Philadelphia, PA, USA; LHMC Lahey Hospital Medical Center, Burlington, MA, USA; MRI Magnetic resonance imaging; NVB Neurovascular Bundle; PDW Proton Density-Weighted; PET Positron emission tomography; Philips Philips Healthcare, Best, the Netherlands; PI-RADS Prostate Imaging-Reporting And Data System; PSA Prostate-specific antigen; RUMC Radboud University Medical Center, Nijmegen, the Netherlands; Siemens Siemens Healthineers, Erlangen, Germany; SV Seminal vesicles; T1W T1-weighted; T2W T2-Weighted; TNCI The National Cancer Institute, Bethesda, MD, USA; TNM Tumor Node Metastasis; UCCUC The University of California Clark Urology Center, Los Angeles, CA, USA; UCL University College London, London, UK; UMCG University Medical Center Groningen, Groningen, the Netherlands; UPMC University of Pittsburgh Medical Center, Pittsburgh, PA, USA; WHSL Washington University in St. Louis, Saint Louis, MO, USA; WRUHC Western Reserve University Hospitals, Cleveland, OH, USA; ZGT Ziekenhuis Groep Twente, Twente, the Netherlands.